Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,907.90Prev. Close
1,898.40Volume
7,07,890Total traded value
131 CrUpper Circuit
2,088.20Lower Circuit
1,708.60Fundamentals
| Market Cap | ₹53,562Cr |
| ROE | 14.89% |
| P/E Ratio(TTM) | 71.06 |
| EPS(TTM) | 26.71 |
| P/B Ratio | 6.05 |
| Dividend Yield | 0.13% |
| Industry P/E | 34.63 |
| Book Value | 313.59 |
| Debt to Equity | 0.28 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Glenmark Pharma
Glenmark is a research-focused global pharmaceutical company making affordable medicines in areas like respiratory, dermatology, and oncology, including well-known brands like Candid and Ascoril. The company's core mission is to make quality healthcare more accessible to people around the world by focusing on continuous innovation and new treatments. It has a significant global commercial presence, with operations in over 80 countries worldwide.;
| Parent Organisation | Glenmark Pharmaceuticals Limited |
| Managing Director | Mr. Glenn Saldanha |
| NSE Symbol | GLENMARK |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.40 | ||
| Cipla | NA (0.00%) | 22.47 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 17.40 | ||
| Mankind Pharma | NA (0.00%) | 51.83 |